What is the Market's View on Agile Therapeutics Inc (AGRX) Stock's Price and Volume Trends Wednesday?

Agile Therapeutics Inc (AGRX) stock is lower by 0.32% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Agile Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on AGRX!

See Full AGRX Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With AGRX Stock Today?

Agile Therapeutics Inc (AGRX) stock is down -0.65% while the S&P 500 has risen 0.45% as of 9:59 AM on Wednesday, Jul 19. AGRX is lower by -$0.02 from the previous closing price of $3.10 on volume of 16,450 shares. Over the past year the S&P 500 is higher by 19.44% while AGRX is lower by -89.02%. AGRX lost -$49.21 per share in the over the last 12 months. To screen for more stocks like Agile Therapeutics Inc click here.

More About Agile Therapeutics Inc

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. Click Here to get the full Stock Report for Agile Therapeutics Inc stock.